Release Date: 28/04/16 08:48 Summary: Acquisition Proposal from Hanesbrands-PBG.AX Price Sensitive: Yes Download Document 3.24MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%